Wang Xiaodong — SEC Form 4 filings
SEC reporting owner CIK 1662982. 17 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-06-07 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 87 legs across 11 filings — 389,111 shares, $91,117,366 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 21,235 shares @ $223.41 ($4,744,092) in BeOne Medicines Ltd., filed 2025-05-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | Director | 17 | — | 87 legs · 389,111 sh · $91,117,366 | 28 |
Form 4 filings — Wang Xiaodong
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,181 @ $345.38 · Sale (S): 2,841 @ $346.16 · Sale (S): 1,517 @ $347.39 · Sale (S): 1,721 @ $348.01 · Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,492 @ $348.31 · +4 more | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 99,892 @ $0 · Grant/award (A): 193,492 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | BeOne Medicines Ltd. (ONC) | Gift (G): 424,073 @ $0 | EDGAR |
| 2025-09-11 | 4 | BeOne Medicines Ltd. (ONC) | Gift (G): 148,096 @ $0 | EDGAR |
| 2025-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 300 @ $263.50 · Sale (S): 1,100 @ $265.35 · Sale (S): 507 @ $266.57 · Sale (S): 100 @ $267.81 | EDGAR |
| 2025-06-12 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 98,696 @ $0 · Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,901 @ $261.20 · Sale (S): 15,878 @ $262.20 · Sale (S): 16,094 @ $263.17 · Sale (S): 6,787 @ $264.08 · +3 more | EDGAR |
| 2025-05-15 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 10,221 @ $222.83 · Sale (S): 21,235 @ $223.41 · Sale (S): 10,104 @ $224.32 · Sale (S): 200 @ $225.68 · Option exercise (M): 542,880 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 995 @ $237.56 · Sale (S): 805 @ $238.48 · Sale (S): 2,884 @ $239.51 · Sale (S): 5,516 @ $240.41 · Sale (S): 2,229 @ $241.51 · +9 more | EDGAR |
| 2025-03-20 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,417 @ $258.25 · Sale (S): 6,926 @ $259.08 · Sale (S): 2,694 @ $259.86 · Sale (S): 10,448 @ $261.44 · Sale (S): 11,245 @ $262.12 · +3 more | EDGAR |
| 2025-03-13 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 158,717 @ $0 | EDGAR |
| 2025-03-06 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 700 @ $251.70 · Sale (S): 2,000 @ $252.72 · Sale (S): 825 @ $253.55 · Sale (S): 1,275 @ $254.77 · Sale (S): 1,214 @ $255.71 · Sale (S): 1,809 @ $256.83 · +1 more | EDGAR |
| 2025-02-06 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 9,099 @ $223.00 · Sale (S): 1,519 @ $224.18 · Sale (S): 2,161 @ $225.27 · Sale (S): 17,805 @ $226.35 · Sale (S): 9,776 @ $227.00 · +2 more | EDGAR |
| 2025-01-08 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 19,251 @ $175.46 · Sale (S): 11,310 @ $176.67 · Sale (S): 4,260 @ $177.42 · Sale (S): 5,638 @ $178.39 · Sale (S): 1,301 @ $179.18 · +1 more | EDGAR |
| 2024-12-12 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,600 @ $183.60 · Sale (S): 7,063 @ $184.83 · Sale (S): 9,956 @ $185.73 · Sale (S): 9,266 @ $186.99 · Sale (S): 6,350 @ $187.60 · +7 more | EDGAR |
| 2024-11-29 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 38,461 @ $6.50 · Sale (S): 4,425 @ $187.16 · Sale (S): 300 @ $187.61 · Sale (S): 5,875 @ $187.98 · Sale (S): 400 @ $188.55 · Sale (S): 2,700 @ $189.17 · +13 more | EDGAR |
| 2024-08-14 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 301,457 @ $0 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 108,992 @ $0 · Grant/award (A): 410,657 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662982 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →